Different 3D domain-swapped oligomeric cyanovirin-N structures suggest trapped folding intermediates

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 19, 2013, Pages 7702-7707

  Koharudin, Leonardus M I ^a   Liu, Lin ^a,b   Gronenborn, Angela M ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CV N; NMR spectroscopy; Protein folding; X ray structures

Indexed keywords

CYANOVIRIN N; DIMER; MONOMER; OLIGOMER; POLYPEPTIDE; PROTEIN VARIANT; TETRAMER;

AMINO ACID SEQUENCE; ARTICLE; BETA SHEET; CONTROLLED STUDY; CRYSTAL STRUCTURE; HETERONUCLEAR SINGLE QUANTUM COHERENCE; NITROGEN NUCLEAR MAGNETIC RESONANCE; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN QUATERNARY STRUCTURE; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; X RAY CRYSTALLOGRAPHY;

CV-N; NMR SPECTROSCOPY; PROTEIN FOLDING; X-RAY STRUCTURES;

BACTERIAL PROTEINS; CARRIER PROTEINS; CRYSTALLOGRAPHY, X-RAY; DIMERIZATION; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR CONFORMATION; NOSTOC; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; PROTEINS; X-RAY DIFFRACTION;

EID: 84877324860     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1300327110     Document Type: Article

References (60)

1. Ecroyd H, Carver JA (2008) Unraveling the mysteries of protein folding and misfolding. IUBMB Life 60(12): 769-774.
2. Lashuel HA, Hartley D, Petre BM, Walz T, Lansbury PT, Jr. (2002) Neurodegenerative disease: Amyloid pores from pathogenic mutations. Nature 418(6895):291.
3. Dobson CM (2003) Protein folding and misfolding. Nature 426(6968): 884-890.
4. Selkoe DJ (2003) Folding proteins in fatal ways. Nature 426(6968): 900-904.
5. Pepys MB (2006) Amyloidosis. Annu Rev Med 57: 223-241.
6. Cleary JP, et al. (2005) Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 8(1): 79-84.
7. Fändrich M, Fletcher MA, Dobson CM (2001) Amyloid fibrils from muscle myoglobin. Nature 410(6825): 165-166.
8. Shtilerman MD, Ding TT, Lansbury PT, Jr. (2002) Molecular crowding accelerates fibrillization of alpha-synuclein: Could an increase in the cytoplasmic protein concentration induce Parkinson's disease? Biochemistry 41(12): 3855-3860.
9. Spillantini MG, et al. (1997) Alpha-synuclein in Lewy bodies. Nature 388(6645): 839-840.
10. Mallucci G, et al. (2003) Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302(5646): 871-874.
11. Balbirnie M, Grothe R, Eisenberg DS (2001) An amyloid-forming peptide from the yeast prion Sup35 reveals a dehydrated beta-sheet structure for amyloid. Proc Natl Acad Sci USA 98(5): 2375-2380.
12. Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S (2004) Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431(7010): 805-810.
13. Perutz MF (1999) Glutamine repeats and neurodegenerative diseases: Molecular aspects. Trends Biochem Sci 24(2): 58-63.
14. Eulalio A, Behm-Ansmant I, Izaurralde E (2007) P bodies: At the crossroads of posttranscriptional pathways. Nat Rev Mol Cell Biol 8(1): 9-22.
15. Parker R, Sheth U (2007) P bodies and the control of mRNA translation and degradation. Mol Cell 25(5): 635-646.
16. Goodsell DS, Olson AJ (2000) Structural symmetry and protein function. Annu Rev Biophys Biomol Struct 29: 105-153.
17. Venkatakrishnan AJ, Levy ED, Teichmann SA (2010) Homomeric protein complexes: Evolution and assembly. Biochem Soc Trans 38(4): 879-882.
18. Ali MH, Imperiali B (2005) Protein oligomerization: How and why. Bioorg Med Chem 13(17): 5013-5020.
19. Marianayagam NJ, Sunde M, Matthews JM (2004) The power of two: Protein dimerization in biology. Trends Biochem Sci 29(11): 618-625.
20. Barrientos LG, Lasala F, Delgado R, Sanchez A, Gronenborn AM (2004) Flipping the switch from monomeric to dimeric CV-N has little effect on antiviral activity. Structure 12(10): 1799-1807.
21. Matei E, Furey W, Gronenborn AM (2008) Solution and crystal structures of a sugar binding site mutant of cyanovirin-N: No evidence of domain swapping. Structure 16 (8): 1183-1194.
22. Fromme R, et al. (2007) A monovalent mutant of cyanovirin-N provides insight into the role of multiple interactions with gp120 for antiviral activity. Biochemistry 46(32): 9199-9207.
23. Barrientos LG, Matei E, Lasala F, Delgado R, Gronenborn AM (2006) Dissecting carbohydrate- Cyanovirin-N binding by structure-guided mutagenesis: Functional implications for viral entry inhibition. Protein Eng Des Sel 19(12): 525-535.
24. Bennett MJ, Schlunegger MP, Eisenberg D (1995) 3D domain swapping: A mechanism for oligomer assembly. Protein Sci 4(12): 2455-2468.
25. Rousseau F, Schymkowitz JW, Itzhaki LS (2003) The unfolding story of threedimensional domain swapping. Structure 11(3): 243-251.
26. Newcomer ME (2002) Protein folding and three-dimensional domain swapping: A strained relationship? Curr Opin Struct Biol 12(1): 48-53.
27. Gronenborn AM (2009) Protein acrobatics in pairs - Dimerization via domain swapping. Curr Opin Struct Biol 19(1): 39-49.
28. Rousseau F, Schymkowitz J, Itzhaki LS (2012) Implications of 3D domain swapping for protein folding, misfolding and function. Adv Exp Med Biol 747: 137-152.
29. Liu Y, Eisenberg D (2002) 3D domain swapping: As domains continue to swap. Protein Sci 11(6): 1285-1299.
30. Liu L, Gronenborn AM (2012) Protein and Nucleic Acid Folding: Domain Swapping in Proteins (Academic, Oxford, UK).
31. Crestfield AM, Stein WH, Moore S (1962) On the aggregation of bovine pancreatic ribonuclease. Arch Biochem Biophys 1(Suppl 1): 217-222.
32. Liu Y, Hart PJ, Schlunegger MP, Eisenberg D (1998) The crystal structure of a 3D domain- swapped dimer of RNase A at a 2.1-A resolution. Proc Natl Acad Sci USA 95(7): 3437-3442.
33. Liu Y, Gotte G, Libonati M, Eisenberg D (2001) A domain-swapped RNase A dimer with implications for amyloid formation. Nat Struct Biol 8(3): 211-214.
34. Liu Y, Gotte G, Libonati M, Eisenberg D (2002) Structures of the two 3D domainswapped RNase A trimers. Protein Sci 11(2): 371-380.
35. Gotte G, Libonati M (2004) Oligomerization of ribonuclease A: Two novel threedimensional domain-swapped tetramers. J Biol Chem 279(35): 36670-36679.
36. Libonati M, Gotte G (2004) Oligomerization of bovine ribonuclease A: Structural and functional features of its multimers. Biochem J 380(Pt 2): 311-327.
37. Gotte G, Laurents DV, Libonati M (2006) Three-dimensional domain-swapped oligomers of ribonuclease A: Identification of a fifth tetramer, pentamers and hexamers, and detection of trace heptameric, octameric and nonameric species. Biochim Biophys Acta 1764(1): 44-54.
38. Gotte G, Libonati M (2008) Oligomerization of ribonuclease A under reducing conditions. Biochim Biophys Acta 1784(4): 638-650.
39. Boyd MR, et al. (1997) Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: Potential applications to microbicide development. Antimicrob Agents Chemother 41 (7): 1521-1530.
40. Yang F, et al. (1999) Crystal structure of cyanovirin-N, a potent HIV-inactivating protein, shows unexpected domain swapping. J Mol Biol 288(3): 403-412.
41. Barrientos LG, et al. (2002) The domain-swapped dimer of cyanovirin-N is in a metastable folded state: Reconciliation of X-ray and NMR structures. Structure 10(5): 673-686.
42. Bewley CA, et al. (1998) Solution structure of cyanovirin-N, a potent HIV-inactivating protein. Nat Struct Biol 5(7): 571-578.
43. Botos I, et al. (2002) Structures of the complexes of a potent anti-HIV protein cyanovirin- N and high mannose oligosaccharides. J Biol Chem 277(37): 34336-34342.
44. Barrientos LG, Gronenborn AM (2002) The domain-swapped dimer of cyanovirin-N contains two sets of oligosaccharide binding sites in solution. Biochem Biophys Res Commun 298(4): 598-602.
45. Zegers I, Deswarte J, Wyns L (1999) Trimeric domain-swapped barnase. Proc Natl Acad Sci USA 96(3): 818-822.
46. Sundaramoorthy M, Meiyappan M, Todd P, Hudson BG (2002) Crystal structure of NC1 domains. Structural basis for type IV collagen assembly in basement membranes. J Biol Chem 277(34): 31142-31153.
47. Yamasaki M, Sendall TJ, Pearce MC, Whisstock JC, Huntington JA (2011) Molecular basis of α1-antitrypsin deficiency revealed by the structure of a domain-swapped trimer. EMBO Rep 12(10): 1011-1017.
48. Kirsten Frank M, Dyda F, Dobrodumov A, Gronenborn AM (2002) Core mutations switch monomeric protein GB1 into an intertwined tetramer. Nat Struct Biol 9(11): 877-885.
49. Pflugrath JW (1999) The finer things in X-ray diffraction data collection. Acta Crystallogr D Biol Crystallogr 55(Pt 10): 1718-1725.
50. Collaborative Computational Project N (1994) The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 50(5): 760-763.
51. McCoy AJ (2007) Solving structures of protein complexes by molecular replacement with Phaser. Acta Crystallogr D Biol Crystallogr 63(Pt 1): 32-41.
52. Emsley P, Cowtan K (2004) Coot: Model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60(Pt 12 Pt 1): 2126-2132.
53. Murshudov GN, Vagin AA, Dodson EJ (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53(Pt 3): 240-255.
54. Davis IW, et al. (2007) MolProbity: All-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 35(Web Server issue):W375-W383.
55. Pettersen EF, et al. (2004) UCSF Chimera - A visualization system for exploratory research and analysis. J Comput Chem 25(13): 1605-1612.
56. DeLano WL (2002) The PyMOL Molecular Graphics System. Available at www.pymol. org.
57. Fiser A, Sali A (2003) Modeller: Generation and refinement of homology-based protein structure models. Methods Enzymol 374: 461-491.
58. Eswar N, Eramian D, Webb B, Shen MY, Sali A (2008) Protein structure modeling with MODELLER. Methods Mol Biol 426: 145-159.
59. Delaglio F, et al. (1995) NMRPipe: A multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6(3): 277-293.
60. Johnson BA, Blevins RA (1994) NMR View: A computer program for the visualization and analysis of NMR data. J Biomol NMR 4(5): 603-614.